Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

NCT06396845 is registered in ClinicalTrials.gov with Daorong Wang as lead sponsor.

NCT NCT06396845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06396845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)
Lead sponsor
Daorong Wang
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
January 3, 2024
Enrollment
505 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior resection for rectal cancer, laparoscopic, robotic